Differential barcoding of opioid receptors trafficking
- PMID: 34559903
- DOI: 10.1002/jnr.24949
Differential barcoding of opioid receptors trafficking
Abstract
Over the past several years, studies have highlighted the δ-opioid receptor (DOPr) as a promising therapeutic target for chronic pain management. While exhibiting milder undesired effects than most currently prescribed opioids, its specific agonists elicit effective analgesic responses in numerous animal models of chronic pain, including inflammatory, neuropathic, diabetic, and cancer-related pain. However, as compared with the extensively studied μ-opioid receptor, the molecular mechanisms governing its trafficking remain elusive. Recent advances have denoted several significant particularities in the regulation of DOPr intracellular routing, setting it apart from the other members of the opioid receptor family. Although they share high homology, each opioid receptor subtype displays specific amino acid patterns potentially involved in the regulation of its trafficking. These precise motifs or "barcodes" are selectively recognized by regulatory proteins and therefore dictate several aspects of the itinerary of a receptor, including its anterograde transport, internalization, recycling, and degradation. With a specific focus on the regulation of DOPr trafficking, this review will discuss previously reported, as well as potential novel trafficking barcodes within the opioid and nociceptin/orphanin FQ opioid peptide receptors, and their impact in determining distinct interactomes and physiological responses.
Keywords: G protein-coupled receptors; motif; nociceptin receptor; opioid receptors; post-translational modification; trafficking.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Abdallah, K., & Gendron, L. (2018). The delta opioid receptor in pain control. Handbook of Experimental Pharmacology, 247, 147-177.
-
- Arvidsson, U., Dado, R. J., Riedl, M., Lee, J. H., Law, P. Y., Loh, H. H., Elde, R., & Wessendorf, M. W. (1995). δ-Opioid receptor immunoreactivity: Distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. Journal of Neuroscience, 15, 1215-1235.
-
- Bannert, N., Craig, S., Farzan, M., Sogah, D., Santo, N. V., Choe, H., & Sodroski, J. (2001). Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. Journal of Experimental Medicine, 194, 1661-1673.
-
- Barak, L. S., Tiberi, M., Freedman, N. J., Kwatra, M. M., Lefkowitz, R. J., & Caron, M. G. (1994). A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated β2-adrenergic receptor sequestration. Journal of Biological Chemistry, 269, 2790-2795.
-
- Bartlett, S. E., Enquist, J., Hopf, F. W., Lee, J. H., Gladher, F., Kharazia, V., Waldhoer, M., Mailliard, W. S., Armstrong, R., Bonci, A., & Whistler, J. L. (2005). Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proceedings of the National Academy of Sciences of the United States of America, 102, 11521-11526.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous